REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Xenico Pharma Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: All Other Food Manufacturing | Miscellaneous Durable Goods Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Department Stores | Administrative Management and General Management Consulting Services | Advertising, Public Relations, and Related Services | Marketing Research and Public Opinion Polling
Full name: Xenico Pharma Sp. z o.o. Profile Updated: April 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Xenico Pharma Sp. z o.o. is based in Poland. The head office is in Wroclaw. The company operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on May 20, 2015. It currently has a total number of 1 (2015) employees. There was a net sales revenue increase of 16.72% reported in Xenico Pharma Sp. z o.o.’s latest financial highlights for 2024. There was a total growth of 28.51% in Xenico Pharma Sp. z o.o.’s total assets over the same period. Xenico Pharma Sp. z o.o.’s net profit margin increased by 1.93% in 2024.

Headquarters
Ul. Bialowieska 91B
Wroclaw; Dolnoslaskie; Postal Code: 54-234

Contact Details: Purchase the Xenico Pharma Sp. z o.o. report to view the information.

Website: http://xenico.pl/

Basic Information
Total Employees:
Purchase the Xenico Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Xenico Pharma Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Xenico Pharma Sp. z o.o. report to view the information.
Incorporation Date:
May 20, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Xenico Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
16.72%▲
Total operating revenue
16.73%▲
Operating profit (EBIT)
92.48%▲
EBITDA
96.53%▲
Net Profit (Loss) for the Period
97.33%▲
Total assets
28.51%▲
Total equity
20.74%▲
Operating Profit Margin (ROS)
2.56%▲
Net Profit Margin
1.93%▲
Return on Equity (ROE)
6.67%▲
Debt to Equity Ratio
32.86%▲
Quick Ratio
-0.11%▼
Cash Ratio
-0.14%▼

Similar companies

Zaklady Farmaceutyczne "Polpharma" S.A.
 
Lek S.A.
Adamed Pharma S.A.
 
Teva Operations Poland Sp. z o.o.
Aflofarm Farmacja Polska Sp. z o.o.
 
"Fresenius Kabi Polska" Sp. z o.o.
Mariusz Krasnodebski sp. k.
 
Drwalewskie Zaklady Przemyslu Bioweterynaryjnego S.A.
Margofarm Sp. z o.o.
 
Uniphar Sp. z o.o.
Zaklad Konfekcjonowania Ziol "Flos" Elzbieta I Jan Glab sp. j.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo